Difference between revisions of "Dermagraft-TC"
Jump to navigation
Jump to search
m (wikified ATS) |
m (adjusted REFjournal) |
||
| Line 31: | Line 31: | ||
}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal | }}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal | ||
|last=Daecher | |last=Daecher | ||
| − | | | + | |init=M |
|title=Circumcision | |title=Circumcision | ||
|journal=Icon | |journal=Icon | ||
Revision as of 23:22, 29 December 2020
Dermagraft-TC is an artifical skin created from harvested foreskins from infant circumcision.[1] It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is FDA approved,[2][3] and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.[4]
References
- ↑
Dermagraft-TC: Overview
, Advanced Biohealing, Inc.. Retrieved 6 March 2011.
Quote:Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
- ↑
Dermagraft-TC
, MediLexicon. Retrieved 6 March 2011.
Quote:...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
- ↑
(28 March 2007)."Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA", Transplant News. Retrieved 6 March 2011.
Quote:...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.
- ↑
Daecher M. Circumcision. Icon. 1998; 2(2): 70-73.
